首页 > 最新文献

Ibrain最新文献

英文 中文
Research progress on the relationship between traumatic brain injury and brain-gut-microbial axis 脑外伤与脑-肠-微生物轴关系的研究进展
Pub Date : 2024-03-30 DOI: 10.1002/ibra.12153
Jie Yu, Yun-Xin Chen, Jin-Wei Wang, Hai-Tao Wu

Traumatic brain injury (TBI) is a common disease with a high rate of death and disability, which poses a serious threat to human health; thus, the effective treatment of TBI has been a high priority. The brain-gut-microbial (BGM) axis, as a bidirectional communication network for information exchange between the brain and gut, plays a crucial role in neurological diseases. This article comprehensively explores the interrelationship between the BGM axis and TBI, including its physiological effects, basic pathophysiology, and potential therapeutic strategies. It highlights how the bidirectional regulatory pathways of the BGM axis could provide new insights into clinical TBI treatment and underscores the necessity for advanced research and development of innovative clinical treatments for TBI.

创伤性脑损伤(TBI)是一种致死率和致残率都很高的常见疾病,对人类健康构成严重威胁,因此,有效治疗创伤性脑损伤已成为当务之急。脑-肠-微生物(BGM)轴作为大脑和肠道之间信息交流的双向通讯网络,在神经系统疾病中起着至关重要的作用。本文全面探讨了脑-肠-微生物轴与创伤性脑损伤之间的相互关系,包括其生理效应、基本病理生理学和潜在的治疗策略。文章强调了 BGM 轴的双向调节途径如何为创伤性脑损伤的临床治疗提供新的见解,并强调了对创伤性脑损伤进行高级研究和开发创新临床治疗方法的必要性。
{"title":"Research progress on the relationship between traumatic brain injury and brain-gut-microbial axis","authors":"Jie Yu,&nbsp;Yun-Xin Chen,&nbsp;Jin-Wei Wang,&nbsp;Hai-Tao Wu","doi":"10.1002/ibra.12153","DOIUrl":"10.1002/ibra.12153","url":null,"abstract":"<p>Traumatic brain injury (TBI) is a common disease with a high rate of death and disability, which poses a serious threat to human health; thus, the effective treatment of TBI has been a high priority. The brain-gut-microbial (BGM) axis, as a bidirectional communication network for information exchange between the brain and gut, plays a crucial role in neurological diseases. This article comprehensively explores the interrelationship between the BGM axis and TBI, including its physiological effects, basic pathophysiology, and potential therapeutic strategies. It highlights how the bidirectional regulatory pathways of the BGM axis could provide new insights into clinical TBI treatment and underscores the necessity for advanced research and development of innovative clinical treatments for TBI.</p>","PeriodicalId":94030,"journal":{"name":"Ibrain","volume":"10 4","pages":"477-487"},"PeriodicalIF":0.0,"publicationDate":"2024-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ibra.12153","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140362443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy and efficacy of ultrasound-guided puncture (vs. computed tomography-guided) in cervical medial branch blocks for cervicogenic pain: A randomized controlled study 超声引导下穿刺(与计算机断层扫描引导下)治疗颈椎内侧支阻滞治疗颈源性疼痛的准确性和有效性:随机对照研究
Pub Date : 2024-03-17 DOI: 10.1002/ibra.12151
Jie Tian, Xin-Yan Li, Yan Yin, Nan Zhao, Hong Xiao, Hui Liu

Cervical medial branch block (CMBB) has been recognized as an effective treatment for cervicogenic pain. Previous studies mostly used ultrasound-guided out-of-plane puncture for CMBB, while this prospective study was designed to investigate the efficacy of ultrasound-guided in-plane puncture, specifically focusing on the new target of CMBB for cervical pain. This study includes two parts: the accuracy study (N = 15, CMBB was completed by ultrasound and confirmed by computed tomography [CT], in which a good distribution percentage of the analgesic solution was observed) and the efficacy study (N = 40, CMBB was completed by ultrasound or CT, while the proportion of pain relief (numerical rating scale) decrease by more than 50% postoperatively was analyzed). The results showed that the good distribution percentage of the analgesic solution was 97.8%. Furthermore, in the early period (30 min and 2 h postoperatively), the proportion of patients with pain relief was lower in the ultrasound group than that in the CT group, especially at 2 h postoperatively (52% vs. 94%). However, at 24 h postoperatively and later, the proportion of patients with pain relief gradually stabilized to about 60%–70%, and lasted for about 2 weeks to 1 month. Therefore, the new target for CMBB, guided by ultrasound in-plane, offers high visibility and accuracy. A single CMBB performed under ultrasound guidance resulted in pain relief comparable to that of a CT-guided procedure (1 day to 1 month postoperatively). This study indicated that CMBB guided by ultrasound in-plane could be regarded as a promising approach for treatment of cervicogenic pain.

颈内侧支阻滞(CMBB)已被认为是治疗颈源性疼痛的有效方法。以往的研究多采用超声引导下平面外穿刺进行 CMBB,而本前瞻性研究旨在探讨超声引导下平面内穿刺的疗效,特别关注 CMBB 治疗颈椎痛的新靶点。本研究包括两部分:准确性研究(15 人,通过超声完成 CMBB,并通过计算机断层扫描[CT]确认,其中观察到镇痛液的良好分布比例)和有效性研究(40 人,通过超声或 CT 完成 CMBB,同时分析术后疼痛缓解(数字评分量表)减少 50%以上的比例)。结果显示,镇痛液的良好分布率为 97.8%。此外,在早期(术后 30 分钟和 2 小时),超声组患者疼痛缓解的比例低于 CT 组,尤其是在术后 2 小时(52% 对 94%)。但在术后 24 小时及以后,疼痛缓解的患者比例逐渐稳定在 60%-70% 左右,并持续约 2 周至 1 个月。因此,在平面内超声引导下的 CMBB 新靶点具有较高的可视性和准确性。在超声引导下进行单次 CMBB 的疼痛缓解效果与 CT 引导下的手术相当(术后 1 天至 1 个月)。这项研究表明,平面内超声引导下的 CMBB 是一种治疗颈源性疼痛的有效方法。
{"title":"Accuracy and efficacy of ultrasound-guided puncture (vs. computed tomography-guided) in cervical medial branch blocks for cervicogenic pain: A randomized controlled study","authors":"Jie Tian,&nbsp;Xin-Yan Li,&nbsp;Yan Yin,&nbsp;Nan Zhao,&nbsp;Hong Xiao,&nbsp;Hui Liu","doi":"10.1002/ibra.12151","DOIUrl":"10.1002/ibra.12151","url":null,"abstract":"<p>Cervical medial branch block (CMBB) has been recognized as an effective treatment for cervicogenic pain. Previous studies mostly used ultrasound-guided out-of-plane puncture for CMBB, while this prospective study was designed to investigate the efficacy of ultrasound-guided in-plane puncture, specifically focusing on the new target of CMBB for cervical pain. This study includes two parts: the accuracy study (<i>N</i> = 15, CMBB was completed by ultrasound and confirmed by computed tomography [CT], in which a good distribution percentage of the analgesic solution was observed) and the efficacy study (<i>N</i> = 40, CMBB was completed by ultrasound or CT, while the proportion of pain relief (numerical rating scale) decrease by more than 50% postoperatively was analyzed). The results showed that the good distribution percentage of the analgesic solution was 97.8%. Furthermore, in the early period (30 min and 2 h postoperatively), the proportion of patients with pain relief was lower in the ultrasound group than that in the CT group, especially at 2 h postoperatively (52% vs. 94%). However, at 24 h postoperatively and later, the proportion of patients with pain relief gradually stabilized to about 60%–70%, and lasted for about 2 weeks to 1 month. Therefore, the new target for CMBB, guided by ultrasound in-plane, offers high visibility and accuracy. A single CMBB performed under ultrasound guidance resulted in pain relief comparable to that of a CT-guided procedure (1 day to 1 month postoperatively). This study indicated that CMBB guided by ultrasound in-plane could be regarded as a promising approach for treatment of cervicogenic pain.</p>","PeriodicalId":94030,"journal":{"name":"Ibrain","volume":"10 1","pages":"34-45"},"PeriodicalIF":0.0,"publicationDate":"2024-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ibra.12151","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140235155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role and limitation of cell therapy in treating neurological diseases 细胞疗法在治疗神经系统疾病中的作用和局限性
Pub Date : 2024-03-12 DOI: 10.1002/ibra.12152
Yu-Qi Li, Peng-Fei Li, Qian Tao, Issam J. A. Abuqeis, Yan-Bin Xiyang

The central role of the brain in governing systemic functions within human physiology underscores its paramount significance as the focal point of physiological regulation. The brain, a highly sophisticated organ, orchestrates a diverse array of physiological processes encompassing motor control, sensory perception, cognition, emotion, and the regulation of vital functions, such as heartbeat, respiration, and hormonal equilibrium. A notable attribute of neurological diseases manifests as the depletion of neurons and the occurrence of tissue necrosis subsequent to injury. The transplantation of neural stem cells (NSCs) into the brain exhibits the potential for the replacement of lost neurons and the reconstruction of neural circuits. Furthermore, the transplantation of other types of cells in alternative locations can secrete nutritional factors that indirectly contribute to the restoration of nervous system equilibrium and the mitigation of neural inflammation. This review summarized a comprehensive investigation into the role of NSCs, hematopoietic stem cells, mesenchymal stem cells, and support cells like astrocytes and microglia in alleviating neurological deficits after cell infusion. Moreover, a thorough assessment was undertaken to discuss extant constraints in cellular transplantation therapies, concurrently delineating indispensable model-based methodologies, specifically on organoids, which were essential for guiding prospective research initiatives in this specialized field.

大脑在调节人体生理系统功能方面发挥着核心作用,这凸显了它作为生理调节焦点的重要意义。大脑作为一个高度精密的器官,协调着各种生理过程,包括运动控制、感官知觉、认知、情感以及对心跳、呼吸和激素平衡等生命功能的调节。神经系统疾病的一个显著特征是神经元耗竭和损伤后组织坏死。将神经干细胞(NSCs)移植到大脑中可替代失去的神经元,重建神经回路。此外,在其他位置移植其他类型的细胞可分泌营养因子,间接促进神经系统平衡的恢复和神经炎症的缓解。这篇综述总结了对NSCs、造血干细胞、间充质干细胞以及星形胶质细胞和小胶质细胞等支持细胞在缓解细胞输注后神经功能缺损方面作用的全面研究。此外,研究人员还进行了全面评估,讨论了细胞移植疗法中的现有限制因素,同时界定了不可或缺的基于模型的方法,特别是关于器官组织的方法,这些方法对于指导这一专业领域的前瞻性研究计划至关重要。
{"title":"Role and limitation of cell therapy in treating neurological diseases","authors":"Yu-Qi Li,&nbsp;Peng-Fei Li,&nbsp;Qian Tao,&nbsp;Issam J. A. Abuqeis,&nbsp;Yan-Bin Xiyang","doi":"10.1002/ibra.12152","DOIUrl":"10.1002/ibra.12152","url":null,"abstract":"<p>The central role of the brain in governing systemic functions within human physiology underscores its paramount significance as the focal point of physiological regulation. The brain, a highly sophisticated organ, orchestrates a diverse array of physiological processes encompassing motor control, sensory perception, cognition, emotion, and the regulation of vital functions, such as heartbeat, respiration, and hormonal equilibrium. A notable attribute of neurological diseases manifests as the depletion of neurons and the occurrence of tissue necrosis subsequent to injury. The transplantation of neural stem cells (NSCs) into the brain exhibits the potential for the replacement of lost neurons and the reconstruction of neural circuits. Furthermore, the transplantation of other types of cells in alternative locations can secrete nutritional factors that indirectly contribute to the restoration of nervous system equilibrium and the mitigation of neural inflammation. This review summarized a comprehensive investigation into the role of NSCs, hematopoietic stem cells, mesenchymal stem cells, and support cells like astrocytes and microglia in alleviating neurological deficits after cell infusion. Moreover, a thorough assessment was undertaken to discuss extant constraints in cellular transplantation therapies, concurrently delineating indispensable model-based methodologies, specifically on organoids, which were essential for guiding prospective research initiatives in this specialized field.</p>","PeriodicalId":94030,"journal":{"name":"Ibrain","volume":"10 1","pages":"93-105"},"PeriodicalIF":0.0,"publicationDate":"2024-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ibra.12152","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140250044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IGF2BP2 modulates autophagy and serves as a prognostic marker in glioma IGF2BP2 可调节自噬,是胶质瘤的预后标志物
Pub Date : 2024-03-11 DOI: 10.1002/ibra.12150
Ning Li, Limei Deng, Yuming Zhang, Xilian Tang, Bingxi Lei, Qingyu Zhang

Glioma, a malignant brain tumor originating from neural glial cells, presents significant treatment challenges. However, the underlying mechanisms of glioma development are not fully understood, and effective targets are lacking. This study provides insights into the role of insulin-like growth factor 2 messenger RNA-binding protein 2 (IGF2BP2) in glioma progression and its therapeutic potential. Our analysis illustrated that elevated IGF2BP2 expression associated with significantly shorter survival among patients with low-grade glioma (LGG) in The Cancer Genome Atlas (TCGA) database. IGF2BP2 depletion led to compromised cell viability, G0/G1 phase arrest, and reduced colony-formation ability. Furthermore, ultrastructural analysis and mCherry-GFP-LC3 reporter assay revealed an increased abundance of autophagosomes upon IGF2BP2 knockdown. Western blot analysis corroborated these findings by showing reduced p62 levels coupled with increased LC3-ІІ/LC3-I ratio upon IGF2BP2 knockdown. A multicolor immunohistochemistry assay demonstrated the positive correlation between IGF2BP2 and p62 expression in glioma patient samples. Additionally, our analysis suggested a link between IGF2BP2 expression and drug-resistant markers in TCGA-LGG samples, and Cell Counting Kit-8 cell viability assay revealed that knockdown of IGF2BP2 sensitized cells to temozolomide treatment. This comprehensive exploration unveils the role of IGF2BP2 in glioma progression, shedding light on autophagy modulation and chemosensitization strategies for glioma therapy.

胶质瘤是一种源自神经胶质细胞的恶性脑肿瘤,给治疗带来了巨大挑战。然而,胶质瘤发展的内在机制尚未完全明了,也缺乏有效的靶点。本研究深入探讨了胰岛素样生长因子2信使RNA结合蛋白2(IGF2BP2)在胶质瘤发展过程中的作用及其治疗潜力。我们的分析表明,在癌症基因组图谱(TCGA)数据库中,IGF2BP2表达升高与低级别胶质瘤(LGG)患者的生存期明显缩短有关。IGF2BP2消耗会导致细胞活力受损、G0/G1期停滞和集落形成能力下降。此外,超微结构分析和mCherry-GFP-LC3报告检测显示,IGF2BP2敲除后自噬体的丰度增加。Western 印迹分析证实了这些发现,显示 IGF2BP2 敲除后 p62 水平降低,LC3-ІІ/LC3-I 比率增加。多色免疫组化分析表明,在胶质瘤患者样本中,IGF2BP2 和 p62 的表达呈正相关。此外,我们的分析表明,在TCGA-LGG样本中,IGF2BP2的表达与耐药标记物之间存在联系,细胞计数试剂盒-8细胞活力测定显示,敲除IGF2BP2可使细胞对替莫唑胺治疗敏感。这一全面探索揭示了IGF2BP2在胶质瘤进展中的作用,为胶质瘤治疗中的自噬调节和化疗增敏策略提供了启示。
{"title":"IGF2BP2 modulates autophagy and serves as a prognostic marker in glioma","authors":"Ning Li,&nbsp;Limei Deng,&nbsp;Yuming Zhang,&nbsp;Xilian Tang,&nbsp;Bingxi Lei,&nbsp;Qingyu Zhang","doi":"10.1002/ibra.12150","DOIUrl":"https://doi.org/10.1002/ibra.12150","url":null,"abstract":"<p>Glioma, a malignant brain tumor originating from neural glial cells, presents significant treatment challenges. However, the underlying mechanisms of glioma development are not fully understood, and effective targets are lacking. This study provides insights into the role of insulin-like growth factor 2 messenger RNA-binding protein 2 (IGF2BP2) in glioma progression and its therapeutic potential. Our analysis illustrated that elevated IGF2BP2 expression associated with significantly shorter survival among patients with low-grade glioma (LGG) in The Cancer Genome Atlas (TCGA) database. IGF2BP2 depletion led to compromised cell viability, G0/G1 phase arrest, and reduced colony-formation ability. Furthermore, ultrastructural analysis and mCherry-GFP-LC3 reporter assay revealed an increased abundance of autophagosomes upon IGF2BP2 knockdown. Western blot analysis corroborated these findings by showing reduced p62 levels coupled with increased LC3-ІІ/LC3-I ratio upon IGF2BP2 knockdown. A multicolor immunohistochemistry assay demonstrated the positive correlation between IGF2BP2 and p62 expression in glioma patient samples. Additionally, our analysis suggested a link between IGF2BP2 expression and drug-resistant markers in TCGA-LGG samples, and Cell Counting Kit-8 cell viability assay revealed that knockdown of IGF2BP2 sensitized cells to temozolomide treatment. This comprehensive exploration unveils the role of IGF2BP2 in glioma progression, shedding light on autophagy modulation and chemosensitization strategies for glioma therapy.</p>","PeriodicalId":94030,"journal":{"name":"Ibrain","volume":"10 1","pages":"19-33"},"PeriodicalIF":0.0,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ibra.12150","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140297260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Walking forward or on hold: Could the ChatGPT be applied for seeking health information in neurosurgical settings? 前行或搁置:ChatGPT 可否应用于神经外科环境中的健康信息搜索?
Pub Date : 2024-03-09 DOI: 10.1002/ibra.12149
Si-Yu Yan, Yi-Fan Liu, Lu Ma, Ling-Long Xiao, Xin Hu, Rui Guo, Chao You, Rui Tian

Self-management is important for patients suffering from cerebrovascular events after neurosurgical procedures. An increasing number of artificial intelligence (AI)-assisted tools have been used in postoperative health management. ChatGPT is a new trend dialog-based chatbot that could be used as a supplemental tool for seeking health information. Responses from ChatGPT version 3.5 and 4.0 toward 13 questions raised by experienced neurosurgeons were evaluated in this exploratory study for their consistency and appropriateness blindly by the other three neurosurgeons. The readability of response text was investigated quantitively by word count and the Gunning Fog and Flesch–Kincaid indices. Results showed that the chatbot could provide relatively stable output between the two versions on consistency and appropriateness (χ² = 0.348). As for readability, there was a higher demand for readers to comprehend the output text in the 4.0 version (more counts of words; lower Flesch–Kincaid reading ease score; and higher Flesch–Kincaid grade level). In general, the capacity of ChatGPT to deliver effective health information is still under debate.

自我管理对于神经外科手术后发生脑血管事件的患者非常重要。越来越多的人工智能(AI)辅助工具被用于术后健康管理。ChatGPT 是一种基于对话的新趋势聊天机器人,可用作寻求健康信息的辅助工具。在这项探索性研究中,其他三位神经外科医生对 ChatGPT 3.5 版和 4.0 版对经验丰富的神经外科医生提出的 13 个问题的回复进行了盲法评估,以确定其一致性和适当性。通过字数、Gunning Fog 和 Flesch-Kincaid 指数对回复文本的可读性进行了量化研究。结果显示,在一致性和适当性方面,两个版本的聊天机器人都能提供相对稳定的输出(χ² = 0.348)。在可读性方面,4.0 版本对读者理解输出文本的要求更高(字数更多;Flesch-Kincaid 阅读容易度得分更低;Flesch-Kincaid 等级更高)。总的来说,ChatGPT 能否提供有效的健康信息仍有待商榷。
{"title":"Walking forward or on hold: Could the ChatGPT be applied for seeking health information in neurosurgical settings?","authors":"Si-Yu Yan,&nbsp;Yi-Fan Liu,&nbsp;Lu Ma,&nbsp;Ling-Long Xiao,&nbsp;Xin Hu,&nbsp;Rui Guo,&nbsp;Chao You,&nbsp;Rui Tian","doi":"10.1002/ibra.12149","DOIUrl":"https://doi.org/10.1002/ibra.12149","url":null,"abstract":"<p>Self-management is important for patients suffering from cerebrovascular events after neurosurgical procedures. An increasing number of artificial intelligence (AI)-assisted tools have been used in postoperative health management. ChatGPT is a new trend dialog-based chatbot that could be used as a supplemental tool for seeking health information. Responses from ChatGPT version 3.5 and 4.0 toward 13 questions raised by experienced neurosurgeons were evaluated in this exploratory study for their consistency and appropriateness blindly by the other three neurosurgeons. The readability of response text was investigated quantitively by word count and the Gunning Fog and Flesch–Kincaid indices. Results showed that the chatbot could provide relatively stable output between the two versions on consistency and appropriateness (<i>χ</i>² = 0.348). As for readability, there was a higher demand for readers to comprehend the output text in the 4.0 version (more counts of words; lower Flesch–Kincaid reading ease score; and higher Flesch–Kincaid grade level). In general, the capacity of ChatGPT to deliver effective health information is still under debate.</p>","PeriodicalId":94030,"journal":{"name":"Ibrain","volume":"10 1","pages":"111-115"},"PeriodicalIF":0.0,"publicationDate":"2024-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ibra.12149","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140297185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perrotta Integrative Clinical Interviews-3 (PICI-3): Development, regulation, updation, and validation of the psychometric instrument for the identification of functional and dysfunctional personality traits and diagnosis of psychopathological disorders, for children (8–10 years), preadolescents (11–13 years), adolescents (14–18 years), adults (19–69 years), and elders (70–90 years) 佩罗塔综合临床访谈-3(PICI-3):针对儿童(8-10 岁)、学龄前儿童(11-13 岁)、青少年(14-18 岁)、成人(19-69 岁)和老年人(70-90 岁)开发、调整、更新和验证用于识别功能性和功能失调性人格特征以及诊断精神病理学障碍的心理测量工具
Pub Date : 2024-02-13 DOI: 10.1002/ibra.12148
Giulio Perrotta

The Perrotta Integrative Clinical Interview, second version (PICI-2) requires structural and functional updates, based on clinical and academic experience, especially in terms of functional traits and interpretation of psychopathological disorders. The Perrotta Integrative Clinical Interviews-3 (PICI-3) was created and structured into four sections, dedicated to dysfunctional traits in children and pre-adolescents (PICI-C-3, 8–13 years) and in adolescents, adults, and the elderly (PICI-TA-3, 14–90 years), to common secondary disorders (PICI-DS-3, 8–90 years) and functional traits (PICI-FT-3, 8–90 years), with the identification of all functional elements and structural aspects of personality according to the model underlying the PICI (IPM). Selecting 1732 subjects, between 8 and 90 years old, the statistical analysis showed that the psychometric test has a well-defined and stable construct, with the variables well represented and positively correlated with other constructs already validated. In particular: (a) the PICI-TA-3 (Section A) was compared with the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF), obtaining 99.3% compatibility of results, with a Pearson's coefficient (R) of 0.999 and p < 0.001; (b) the PICI-C-3 (Section B) was compared with the Child Behavior Checklist (CBCL), obtaining 94.1% compatibility of results, with a Pearson coefficient (R) of 0.969 and p < 0.001; (c) the PICI-FT-3 (Section D) was compared with the Big Five Personality Test (Big5), obtaining 89.4% compatibility of results, with a Pearson coefficient (R) of 0.797 and p < 0.001. The PICI-3 is a valid, efficient, and effective psychometric tool to identify the functioning or dysfunction of personality traits for psychopathological diagnosis.

佩罗塔综合临床访谈第二版(PICI-2)需要根据临床和学术经验进行结构和功能上的更新,尤其是在功能特质和精神病理障碍的解释方面。佩罗塔综合临床访谈-3(PICI-3)由四个部分组成,分别针对儿童和学龄前儿童(PICI-C-3,8-13 岁)以及青少年、成人和老年人(PICI-TA-3,14-90 岁)的功能失调特质,以及常见的心理障碍、14-90岁)、常见继发性障碍(PICI-DS-3,8-90岁)和功能性特质(PICI-FT-3,8-90岁),并根据 PICI(IPM)的基础模型识别人格的所有功能性要素和结构方面。统计分析显示,该心理测验具有定义明确且稳定的结构,变量代表性强,并与其他已验证的结构呈正相关。特别是:(a) PICI-TA-3(A 部分)与明尼苏达多相人格量表-2-重组表(MMPI-2-RF)进行了比较,结果吻合度为 99.3%,皮尔逊系数(R)为 0.999,p< 0.001;(b) PICI-C-3(B 部分)与儿童行为检查表(CBCL)进行了比较,结果吻合度为 94.1%,皮尔逊系数(R)为 0.999,p< 0.001;(c) PICI-C-3(B 部分)与儿童行为检查表(CBCL)进行了比较,结果吻合度为 94.1%,皮尔逊系数(R)为 0.999,p< 0.001。(c) 将 PICI-FT-3(D 部分)与大五人格测试(Big5)进行比较,结果的吻合度为 89.4%,皮尔逊系数(R)为 0.797,p 值为 0.001。PICI-3 是一种有效、高效的心理测量工具,可用于鉴定人格特征的功能或功能障碍,从而进行精神病理学诊断。
{"title":"Perrotta Integrative Clinical Interviews-3 (PICI-3): Development, regulation, updation, and validation of the psychometric instrument for the identification of functional and dysfunctional personality traits and diagnosis of psychopathological disorders, for children (8–10 years), preadolescents (11–13 years), adolescents (14–18 years), adults (19–69 years), and elders (70–90 years)","authors":"Giulio Perrotta","doi":"10.1002/ibra.12148","DOIUrl":"https://doi.org/10.1002/ibra.12148","url":null,"abstract":"<p>The Perrotta Integrative Clinical Interview, second version (PICI-2) requires structural and functional updates, based on clinical and academic experience, especially in terms of functional traits and interpretation of psychopathological disorders. The Perrotta Integrative Clinical Interviews-3 (PICI-3) was created and structured into four sections, dedicated to dysfunctional traits in children and pre-adolescents (PICI-C-3, 8–13 years) and in adolescents, adults, and the elderly (PICI-TA-3, 14–90 years), to common secondary disorders (PICI-DS-3, 8–90 years) and functional traits (PICI-FT-3, 8–90 years), with the identification of all functional elements and structural aspects of personality according to the model underlying the PICI (IPM). Selecting 1732 subjects, between 8 and 90 years old, the statistical analysis showed that the psychometric test has a well-defined and stable construct, with the variables well represented and positively correlated with other constructs already validated. In particular: (a) the PICI-TA-3 (Section A) was compared with the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF), obtaining 99.3% compatibility of results, with a Pearson's coefficient (<i>R</i>) of 0.999 and <i>p</i> &lt; 0.001; (b) the PICI-C-3 (Section B) was compared with the Child Behavior Checklist (CBCL), obtaining 94.1% compatibility of results, with a Pearson coefficient (<i>R</i>) of 0.969 and <i>p</i> &lt; 0.001; (c) the PICI-FT-3 (Section D) was compared with the Big Five Personality Test (Big5), obtaining 89.4% compatibility of results, with a Pearson coefficient (<i>R</i>) of 0.797 and <i>p</i> &lt; 0.001. The PICI-3 is a valid, efficient, and effective psychometric tool to identify the functioning or dysfunction of personality traits for psychopathological diagnosis.</p>","PeriodicalId":94030,"journal":{"name":"Ibrain","volume":"10 2","pages":"146-163"},"PeriodicalIF":0.0,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ibra.12148","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141441301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroanatomical and functional correlates in post-traumatic stress disorder: A narrative review 创伤后应激障碍的神经解剖和功能相关性:叙述性综述
Pub Date : 2024-01-19 DOI: 10.1002/ibra.12147
Anna S. Liberati, Giulio Perrotta

Post-traumatic stress disorder (PTSD), currently included by the Diagnostic and Statistical of Mental Disorders, Fifth Edition, Text Revision in the macro-category “disorders related to traumatic and stressful events”, is a severe mental distress that arises acutely as a result of direct or indirect exposure to severely stressful and traumatic events. A large body of literature is available on the psychological and behavioral manifestations of PTSD; however, with regard to the more purely neuropsychological aspects of the disorder, they are still the subject of research and need greater clarity, although the roles of the thalamus, hypothalamus, amygdala, cingulate gyrus, cerebellum, locus coeruleus, and hippocampus in the onset of the disorder's characteristic symptoms have already been elucidated.

创伤后应激障碍(PTSD)目前被《精神疾病诊断与统计》第五版文本修订版列入 "与创伤和应激事件有关的障碍 "这一宏观类别,是一种严重的精神痛苦,是由于直接或间接遭受严重应激和创伤事件而引起的。尽管丘脑、下丘脑、杏仁核、扣带回、小脑、垂体和海马在创伤后应激障碍特征性症状的发生中的作用已被阐明,但有关创伤后应激障碍的心理和行为表现的大量文献仍在研究之中,需要进一步澄清。
{"title":"Neuroanatomical and functional correlates in post-traumatic stress disorder: A narrative review","authors":"Anna S. Liberati,&nbsp;Giulio Perrotta","doi":"10.1002/ibra.12147","DOIUrl":"10.1002/ibra.12147","url":null,"abstract":"<p>Post-traumatic stress disorder (PTSD), currently included by the Diagnostic and Statistical of Mental Disorders, Fifth Edition, Text Revision in the macro-category “disorders related to traumatic and stressful events”, is a severe mental distress that arises acutely as a result of direct or indirect exposure to severely stressful and traumatic events. A large body of literature is available on the psychological and behavioral manifestations of PTSD; however, with regard to the more purely neuropsychological aspects of the disorder, they are still the subject of research and need greater clarity, although the roles of the thalamus, hypothalamus, amygdala, cingulate gyrus, cerebellum, locus coeruleus, and hippocampus in the onset of the disorder's characteristic symptoms have already been elucidated.</p>","PeriodicalId":94030,"journal":{"name":"Ibrain","volume":"10 1","pages":"46-58"},"PeriodicalIF":0.0,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ibra.12147","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139613305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemiplegia in acute ischemic stroke: A comprehensive review of case studies and the role of intravenous thrombolysis and mechanical thrombectomy 急性缺血性中风偏瘫:病例研究综述以及静脉溶栓和机械取栓术的作用
Pub Date : 2024-01-13 DOI: 10.1002/ibra.12146
Karen Adriana Carrillo Navarrete, Christian Chapa González

Acute ischemic stroke is a significant health concern worldwide, often leading to long-term disability and decreased quality of life. Rapid and appropriate treatment is crucial for achieving optimal outcomes in these patients. Intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) are two commonly used interventions for acute ischemic stroke, but their effectiveness in improving neurological symptoms and functional outcomes in patients with hemiplegia remains uncertain. The aim of this work was to evaluate the impact of IVT and MT within a 4.5-h time frame on patients with acute ischemic stroke and hemiplegia. A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Relevant studies that assessed the impact of IVT and MT within 4.5-h on hemiplegia in patients with an acute ischemic stroke were included. Data were extracted and analyzed to determine the overall effects of these interventions. Most included case reports indicate positive outcomes in terms of neurological symptom improvement and functional recovery in patients with hemiplegia after receiving IVT and MT within the specified time frame. However, the heterogeneity among the patients and the limited use of IVT due to contraindications posed challenges in determining the most effective treatment option. The findings from the included studies demonstrate that both interventions led to a decrease in National Institutes of Health Stroke Scale scores, indicating an improvement in neurological symptoms. The results highlight the beneficial effects of early thrombolytic interventions and MT on the neurological status and functional outcomes of patients with an acute ischemic stroke.

急性缺血性脑卒中是全球关注的重大健康问题,通常会导致长期残疾和生活质量下降。快速、适当的治疗是这些患者获得最佳预后的关键。静脉溶栓(IVT)和机械血栓切除术(MT)是急性缺血性中风的两种常用干预方法,但它们在改善偏瘫患者神经症状和功能预后方面的效果仍不确定。本研究旨在评估在 4.5 小时内进行 IVT 和 MT 对急性缺血性卒中偏瘫患者的影响。我们按照《系统综述和元分析首选报告项目》指南进行了系统综述。纳入了评估 4.5 小时内 IVT 和 MT 对急性缺血性卒中患者偏瘫影响的相关研究。对数据进行了提取和分析,以确定这些干预措施的总体效果。大多数纳入的病例报告显示,在规定时间内接受 IVT 和 MT 治疗的偏瘫患者在神经症状改善和功能恢复方面取得了积极成果。然而,患者之间的异质性以及因禁忌症而限制 IVT 的使用给确定最有效的治疗方案带来了挑战。纳入研究的结果表明,两种干预方法都能降低美国国立卫生研究院卒中量表评分,表明神经症状有所改善。研究结果凸显了早期溶栓干预和 MT 对急性缺血性卒中患者神经功能状态和功能预后的有利影响。
{"title":"Hemiplegia in acute ischemic stroke: A comprehensive review of case studies and the role of intravenous thrombolysis and mechanical thrombectomy","authors":"Karen Adriana Carrillo Navarrete,&nbsp;Christian Chapa González","doi":"10.1002/ibra.12146","DOIUrl":"10.1002/ibra.12146","url":null,"abstract":"<p>Acute ischemic stroke is a significant health concern worldwide, often leading to long-term disability and decreased quality of life. Rapid and appropriate treatment is crucial for achieving optimal outcomes in these patients. Intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) are two commonly used interventions for acute ischemic stroke, but their effectiveness in improving neurological symptoms and functional outcomes in patients with hemiplegia remains uncertain. The aim of this work was to evaluate the impact of IVT and MT within a 4.5-h time frame on patients with acute ischemic stroke and hemiplegia. A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Relevant studies that assessed the impact of IVT and MT within 4.5-h on hemiplegia in patients with an acute ischemic stroke were included. Data were extracted and analyzed to determine the overall effects of these interventions. Most included case reports indicate positive outcomes in terms of neurological symptom improvement and functional recovery in patients with hemiplegia after receiving IVT and MT within the specified time frame. However, the heterogeneity among the patients and the limited use of IVT due to contraindications posed challenges in determining the most effective treatment option. The findings from the included studies demonstrate that both interventions led to a decrease in National Institutes of Health Stroke Scale scores, indicating an improvement in neurological symptoms. The results highlight the beneficial effects of early thrombolytic interventions and MT on the neurological status and functional outcomes of patients with an acute ischemic stroke.</p>","PeriodicalId":94030,"journal":{"name":"Ibrain","volume":"10 1","pages":"59-68"},"PeriodicalIF":0.0,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ibra.12146","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139531063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bibliometric analysis of hot literature on neural circuit research 神经回路研究热点文献的文献计量分析
Pub Date : 2023-12-21 DOI: 10.1002/ibra.12144
Ruo-Lan Du, David H. Mauki, Zong-Fu Zuo

Numerous brain diseases have been attributed to abnormalities in the connections of neural circuits. Exploration of neural circuits may give enlightenment in treating some intractable brain diseases. Here, we screened all publications on neural circuits in the Web of Science database from 2007 to 2022 and analyzed the research trends through VOSviewer, CiteSpace, Microsoft Excel 2019, and Origin. The findings revealed a consistent upward trend in research on neural circuits during this period. The United States emerged as the leading contributor, followed by China and Japan. Among the top 10 institutions with the largest number of publications, both the United States and China have a strong presence. Notably, the Chinese Academy of Sciences demonstrated the highest publication output, closely followed by Stanford University. In terms of influential authors, Karl Deisseroth stood out as one of the most prominent investigators. During this period, the majority of publications and citations on neural circuit research were found in highly influential journals including NEURON, NATURE JOURNAL OF NEUROSCIENCE, and so forth. Keyword clustering analysis highlighted the increasing focus on neural circuits and photogenetics in neuroscience research, and the reconstruction of neural circuits has emerged as a crucial research direction in brain science. In conclusion, over the past 15 years, the increasing high-quality publications have facilitated research development of neural circuits, indicating a promising prospect for investigations on neurological and psychiatric diseases.

许多脑部疾病都归因于神经回路连接的异常。对神经回路的探索可能会为治疗某些难治性脑部疾病带来启示。在此,我们筛选了2007年至2022年科学网数据库中所有关于神经回路的论文,并通过VOSviewer、CiteSpace、Microsoft Excel 2019和Origin分析了研究趋势。研究结果表明,在此期间有关神经回路的研究呈持续上升趋势。美国成为主要贡献国,中国和日本紧随其后。在发表论文数量最多的前 10 个机构中,美国和中国都占有很大比重。值得注意的是,中国科学院的出版物数量最多,紧随其后的是斯坦福大学。在有影响力的作者方面,卡尔-戴瑟罗特(Karl Deisseroth)是最杰出的研究者之一。在此期间,有关神经回路研究的大部分论文和引文都发表在极具影响力的期刊上,包括《神经元》(NEURON)、《自然神经科学杂志》(NATURE JOURNAL OF NEUROSCIENCE)等。关键词聚类分析凸显了神经科学研究对神经回路和光遗传学的日益关注,神经回路的重建已成为脑科学的一个重要研究方向。总之,在过去的 15 年中,越来越多的高质量论文促进了神经回路研究的发展,预示着神经和精神疾病研究的美好前景。
{"title":"Bibliometric analysis of hot literature on neural circuit research","authors":"Ruo-Lan Du,&nbsp;David H. Mauki,&nbsp;Zong-Fu Zuo","doi":"10.1002/ibra.12144","DOIUrl":"10.1002/ibra.12144","url":null,"abstract":"<p>Numerous brain diseases have been attributed to abnormalities in the connections of neural circuits. Exploration of neural circuits may give enlightenment in treating some intractable brain diseases. Here, we screened all publications on neural circuits in the Web of Science database from 2007 to 2022 and analyzed the research trends through VOSviewer, CiteSpace, Microsoft Excel 2019, and Origin. The findings revealed a consistent upward trend in research on neural circuits during this period. The United States emerged as the leading contributor, followed by China and Japan. Among the top 10 institutions with the largest number of publications, both the United States and China have a strong presence. Notably, the Chinese Academy of Sciences demonstrated the highest publication output, closely followed by Stanford University. In terms of influential authors, Karl Deisseroth stood out as one of the most prominent investigators. During this period, the majority of publications and citations on neural circuit research were found in highly influential journals including NEURON, NATURE JOURNAL OF NEUROSCIENCE, and so forth. Keyword clustering analysis highlighted the increasing focus on neural circuits and photogenetics in neuroscience research, and the reconstruction of neural circuits has emerged as a crucial research direction in brain science. In conclusion, over the past 15 years, the increasing high-quality publications have facilitated research development of neural circuits, indicating a promising prospect for investigations on neurological and psychiatric diseases.</p>","PeriodicalId":94030,"journal":{"name":"Ibrain","volume":"10 1","pages":"69-82"},"PeriodicalIF":0.0,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ibra.12144","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138951763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical effectiveness and treatment satisfaction between two triple‐therapy regimens in treating neuropathic pain: A real‐world data 两种三联疗法治疗神经病理性疼痛的临床疗效和治疗满意度:真实世界数据
Pub Date : 2023-12-10 DOI: 10.1002/ibra.12143
Nithya Raju, Samyuktha Villavan, Saranya Ravi, Roja Murugesan, Panneerselvam Theivendren, Vennila Jaganathan, Redlin Jani Rajan, K. Karunanithi
Triple‐therapy regimens involving Pregabalin or Gabapentin with nortriptyline and Methylcobalamin have been shown to be efficacious in treating neuropathic pain in clinical trials. This study aims to compare the clinical effectiveness and treatment satisfaction of two triple‐therapy regimens in treating neuropathic pain in a real‐world setting. This prospective, single‐center, observational study compared the efficacy, safety, and treatment satisfaction of triple therapy in Pregabalin triple therapy versus Gabapentin triple therapy for patients with neuropathic pain. The primary outcome measured the reduction in mean Self‐Administered Leeds Assessment of Neuropathic Symptoms and Signs pain score value from the baseline to 12 weeks posttreatment. The secondary outcome measured the treatment satisfaction for both therapies using the Treatment Satisfaction Questionnaire for Medication version 1.4. Of 264 patients who received either treatment group, during the third follow‐up, it became evident that Group A Pregabalin triple therapy yielded a significantly more substantial reduction in neuropathic pain (60.61%) when compared to Group B Gabapentin triple therapy (12.88%). Furthermore, patients expressed markedly higher levels of satisfaction and convenience with the Pregabalin treatment (p ≤ 0.001). Our study's findings, encompassing both clinical effectiveness and treatment satisfaction, unequivocally demonstrate that Group A surpasses Group B in ameliorating neuropathic symptoms and signs. Pregabalin is a more effective and convenient treatment for neuropathic pain than Gabapentin, with no significant difference in side effects. Clinicians should consider Pregabalin as a first‐line treatment option for neuropathic pain, especially for patients not responding to Gabapentin or who seek a more convenient option.
在临床试验中,包括普瑞巴林或加巴喷丁与去甲替林和甲钴胺的三联治疗方案已被证明对神经性疼痛有效。本研究旨在比较现实世界中两种三联疗法治疗神经性疼痛的临床疗效和治疗满意度。这项前瞻性、单中心、观察性研究比较了普瑞巴林三联疗法与加巴喷丁三联疗法对神经性疼痛患者的疗效、安全性和治疗满意度。主要结局测量了自基线至治疗后12周的平均自我给予的利兹神经性症状和体征评估疼痛评分值的减少。次要结局采用1.4版药物治疗满意度问卷测量两种疗法的治疗满意度。在接受任何一种治疗组的264名患者中,在第三次随访期间,很明显,A组普瑞巴林三联治疗比B组加巴喷丁三联治疗(12.88%)在神经性疼痛的减少(60.61%)上取得了更显著的效果。此外,患者对普瑞巴林治疗的满意度和便利性也明显提高(p≤0.001)。我们的研究结果,包括临床疗效和治疗满意度,明确表明A组在改善神经性症状和体征方面优于B组。普瑞巴林治疗神经性疼痛比加巴喷丁更有效、更方便,副作用无显著差异。临床医生应考虑将普瑞巴林作为神经性疼痛的一线治疗选择,特别是对加巴喷丁无效或寻求更方便选择的患者。
{"title":"Clinical effectiveness and treatment satisfaction between two triple‐therapy regimens in treating neuropathic pain: A real‐world data","authors":"Nithya Raju, Samyuktha Villavan, Saranya Ravi, Roja Murugesan, Panneerselvam Theivendren, Vennila Jaganathan, Redlin Jani Rajan, K. Karunanithi","doi":"10.1002/ibra.12143","DOIUrl":"https://doi.org/10.1002/ibra.12143","url":null,"abstract":"Triple‐therapy regimens involving Pregabalin or Gabapentin with nortriptyline and Methylcobalamin have been shown to be efficacious in treating neuropathic pain in clinical trials. This study aims to compare the clinical effectiveness and treatment satisfaction of two triple‐therapy regimens in treating neuropathic pain in a real‐world setting. This prospective, single‐center, observational study compared the efficacy, safety, and treatment satisfaction of triple therapy in Pregabalin triple therapy versus Gabapentin triple therapy for patients with neuropathic pain. The primary outcome measured the reduction in mean Self‐Administered Leeds Assessment of Neuropathic Symptoms and Signs pain score value from the baseline to 12 weeks posttreatment. The secondary outcome measured the treatment satisfaction for both therapies using the Treatment Satisfaction Questionnaire for Medication version 1.4. Of 264 patients who received either treatment group, during the third follow‐up, it became evident that Group A Pregabalin triple therapy yielded a significantly more substantial reduction in neuropathic pain (60.61%) when compared to Group B Gabapentin triple therapy (12.88%). Furthermore, patients expressed markedly higher levels of satisfaction and convenience with the Pregabalin treatment (p ≤ 0.001). Our study's findings, encompassing both clinical effectiveness and treatment satisfaction, unequivocally demonstrate that Group A surpasses Group B in ameliorating neuropathic symptoms and signs. Pregabalin is a more effective and convenient treatment for neuropathic pain than Gabapentin, with no significant difference in side effects. Clinicians should consider Pregabalin as a first‐line treatment option for neuropathic pain, especially for patients not responding to Gabapentin or who seek a more convenient option.","PeriodicalId":94030,"journal":{"name":"Ibrain","volume":"3 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138585328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ibrain
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1